-
UPDATE: Ligand Pharmaceuticals Posts In-Line Q4 Earnings, Issues Weak Outlook
Monday, February 9, 2015 - 10:17am | 208Ligand Pharmaceuticals Inc. (NASDAQ: LGND) reported in-line earnings for the fourth quarter. The La Jolla, California-based company posted a quarterly profit of $7.1 million, or $0.34 per share, versus $1.9 million, or $0.09 per share, in the year-ago period. Non-GAAP net income from continuing...
-
Earnings Scheduled For February 9, 2015
Monday, February 9, 2015 - 5:58am | 978Hasbro Inc. (NASDAQ: HAS) is expected to report its Q4 earnings at $1.21 per share on revenue of $1.33 billion. CNA Financial Corporation (NYSE: CNA) is projected to report its Q4 earnings at $0.80 per share on revenue of $2.29 billion. Loews Corporation (NYSE: L) is expected to report its Q4...
-
Should Ligand Pharmaceuticals Worry Investors?
Friday, February 6, 2015 - 2:22pm | 1062Want an edge on biotech stocks? Try this. Learn more about investing in the biotech sector with real-time trading picks from experts like the Biotech Trader. Ligand Pharmaceuticals Inc. (NASDAQ: LGND) is scheduled to report fourth-quarter 2014 results before the opening bell on February 9,...
-
Stocks Hitting 52-Week Highs
Thursday, January 15, 2015 - 11:25am | 132Advent Software, Inc. (NASDAQ: ADVS) shares reached a new 52-week high of $35.71. Advent Software's trailing-twelve-month operating margin is 21.59%. Neurocrine Biosciences Inc. (NASDAQ: NBIX) shares rose 1.68% to touch a new 52-week high of $31.50. Neurocrine Biosciences shares have jumped 58....
-
Benzinga's Volume Movers
Thursday, January 8, 2015 - 11:33am | 189Neurocrine Biosciences Inc. (NASDAQ: NBIX) surged 21.07% to $26.49. The volume of Neurocrine Biosciences shares traded 1407% higher than normal. AbbVie Inc. (NYSE: ABBV), in cooperation with Neurocrine Biosciences, announced positive top-line results from Phase 3 study of investigational...
-
Stocks Hitting 52-Week Highs
Thursday, January 8, 2015 - 11:22am | 159Neurocrine Biosciences Inc. (NASDAQ: NBIX) shares reached a new 52-week high of $27.62 after AbbVie Inc. (NYSE: ABBV), in cooperation with Neurocrine Biosciences, announced positive top-line results from Phase 3 study of investigational medicine elagolix. Impax Laboratories Inc. (NASDAQ: IPXL)...
-
Morning Market Gainers
Thursday, January 8, 2015 - 10:45am | 459BIND Therapeutics, Inc.(NASDAQ: BIND) shares gained 40.19% to $7.22 after the company provided clinical update for BIND-014. China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) jumped 32.92% to $3.19 after the company signed strategic service agreement with Alipay. Biodel Inc (NASDAQ: BIOD) shares...
-
Benzinga's Top #PreMarket Gainers
Thursday, January 8, 2015 - 9:12am | 186Biodel Inc (NASDAQ: BIOD) shares jumped 42.07% to $2.06 in pre-market trading after the company reported positive preliminary results from Phase 2a clinical trial of BIOD-531. BIND Therapeutics, Inc.(NASDAQ: BIND) shares rose 40.78% to $7.25 in pre-market trading after the company provided...
-
Conkwest Appoints Robert Rosen And Henry Ji To Its Board Of Directors
Monday, December 29, 2014 - 3:45pm | 608Conkwest, Inc. (the Natural Killer Cell Company of the West), an immuno-oncology company developing Neukoplast™ (NK-92™), a proprietary Natural Killer (NK) cell-line based therapy, announces the appointments of Robert Rosen and Henry Ji, Ph.D. to the Company's Board of Directors. Mr. Rosen is...
-
Metabolix Provides Update on Biopolymer Manufacturing Plans
Monday, December 22, 2014 - 5:15pm | 288cMetabolix, Inc. (NASDAQ: MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today provided an update on the Company's biopolymer manufacturing plans. In the second half of 2014, Metabolix conducted a manufacturing site assessment, which included...
-
Benzinga's Volume Movers
Tuesday, December 16, 2014 - 11:37am | 170VeriFone Systems (NYSE: PAY) surged 5.11% to $34.75. The volume of VeriFone shares traded 427% higher than normal. VeriFone reported better-than-expected fourth-quarter results. La Jolla Pharmaceutical Co (NASDAQ: LJPC) shares rose 5.04% to $14.81. The volume of La Jolla Pharmaceutical shares...
-
Neurocrine Biosciences Reports Expansion of Clinical Pipeline
Wednesday, December 10, 2014 - 9:02am | 396Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that NBI-77860, a proprietary corticotropin releasing factor 1 (CRF) receptor antagonist, has entered clinical trials for the treatment of classic congenital adrenal hyperplasia (CAH) a disease that affects approximately 20,000-30,000...
-
Stocks Hitting 52-Week Lows
Friday, November 21, 2014 - 11:01am | 170On Track Innovations (NASDAQ: OTIV) shares tumbled 15% to touch a new 52-week low of $1.62 after the company announced the pricing of public offering of 6.25 million ordinary shares at a price of $1.60 per share. MOL Global (NASDAQ: MOLG) shares reached a new 52-week low of $5.70 after the company...
-
US Stock Futures Rise Ahead Of Earnings
Friday, November 21, 2014 - 8:35am | 405Pre-open movers US stock futures traded higher in early pre-market trade. The Kansas City Fed manufacturing index for November will be released at 11:00 a.m. ET. Futures for the Dow Jones Industrial Average climbed 114 points to 17,808.00, while the Standard & Poor's 500 index futures jumped 13...
-
Mid-Afternoon Market Update: Best Buy Rises After Upbeat Results; GoPro Shares Slide
Thursday, November 20, 2014 - 3:48pm | 820Toward the end of trading Thursday, the Dow traded up 0.11 percent to 17,704.39 while the NASDAQ gained 0.53 percent to 4,700.44. The S&P also rose, gaining 0.19 percent to 2,052.50. Leading and Lagging Sectors Energy shares jumped by 0.88 percent on Thursday. Top gainers in the sector...